06th week of 2021 patent applcation highlights part 25 |
Patent application number | Title | Published |
20210040097 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | 2021-02-11 |
20210040098 | APELIN RECEPTOR AGONISTS AND METHODS OF USE THEREOF | 2021-02-11 |
20210040099 | Compounds for the Treatment of Kinase-Dependent Disorders | 2021-02-11 |
20210040100 | JAK INHIBITORS | 2021-02-11 |
20210040101 | SUBSTITUTED PYRROLOTRIAZINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 2021-02-11 |
20210040102 | IMIDAZO-FUSED HETEROCYCLES AND USES THEREOF | 2021-02-11 |
20210040103 | GABAA POSITIVE ALLOSTERIC MODULATOR COMPOUNDS, METHODS OF MAKING, AND USES THEREOF | 2021-02-11 |
20210040104 | NOVEL KINASE INHIBITORS EXHIBITING ANTI-CANCER ACTIVITY AND THEIR METHOD OF USE | 2021-02-11 |
20210040105 | Thermally Sensitive Protecting Groups for Cysteine, and Manufacture and Use Thereof | 2021-02-11 |
20210040106 | METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO [2,3-F] CHROMENE DERIVATIVE | 2021-02-11 |
20210040107 | PROCESS FOR THE PREPARATION OF ERIBULIN MESYLATE INTERMEDIATE | 2021-02-11 |
20210040108 | Inhibitors of RAD52 Recombination Protein and Methods Using Same | 2021-02-11 |
20210040109 | BIPHENYL-CONTAINING DIARYLPYRIMIDO COMPOUNDS, PHARMACEUTICALLY-ACCEPTABLE SALTS THEREOF, COMPOSITION AND PREPARATION THEREOF | 2021-02-11 |
20210040110 | POLYMERS CONTAINING INDACEN-4-ONE DERIVATIVES | 2021-02-11 |
20210040111 | DRUGS TO TREAT OCULAR DISORDERS | 2021-02-11 |
20210040112 | HETEROACENE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | 2021-02-11 |
20210040113 | PYRAZOLE- AND INDAZOLE- SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS | 2021-02-11 |
20210040114 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINOLINE TYPE COMPOUND, PREPARATION METHOD AND USES THEREOF | 2021-02-11 |
20210040115 | FUSED RING HETEROARYL COMPOUNDS AS RIPK1 INHIBITORS | 2021-02-11 |
20210040116 | New Polymorphs of Dolutegravir Sodium | 2021-02-11 |
20210040117 | CONDENSED RING COMPOUNDS HAVING DOPAMINE D3 RECEPTOR ANTAGONISTIC EFFECT | 2021-02-11 |
20210040118 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | 2021-02-11 |
20210040119 | PROCESS FOR THE PREPARATION OF A SUBSTITUTED IMIDAZOTHIAZOLONE COMPOUND | 2021-02-11 |
20210040120 | COMPOUNDS THAT INHIBIT MCL-1 PROTEIN | 2021-02-11 |
20210040121 | FUSED POLYCYCLIC DIMERS | 2021-02-11 |
20210040122 | FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATE INHIBITORS | 2021-02-11 |
20210040123 | PREPARATION METHOD OF AN ENERGETIC COORDINATION COMPOUND WITH 5-METHYLTETRAZOLE | 2021-02-11 |
20210040124 | Organolithium Process Under Continuous Flow Conditions | 2021-02-11 |
20210040125 | POLYMERIZATION INHIBITOR FOR N-VINYL PYRROLIDONE MONOMER AND USE THEREOF | 2021-02-11 |
20210040126 | 68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS | 2021-02-11 |
20210040127 | ARGINASE INHIBITORS AND METHODS OF USE | 2021-02-11 |
20210040128 | NOVEL DIPHENYLMETHANE PROTECTIVE AGENT | 2021-02-11 |
20210040129 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-02-11 |
20210040130 | NIOBIUM COMPOUND AND METHOD OF FORMING THIN FILM | 2021-02-11 |
20210040131 | DECOLORIZATION OF CONCENTRATED RHAMNOLIPID COMPOSITION | 2021-02-11 |
20210040132 | NOVEL COMPOUND FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE AND APPLICATION THEREOF | 2021-02-11 |
20210040133 | FOOD OR FEED COMPOSITION FOR IMPROVING COGNITIVE FUNCTION OR MEMORY COMPRISING EXTRACT OF DESALTED SALICORNIA EUROPAEA | 2021-02-11 |
20210040134 | COMBINATIONS OF MACROLIDE COMPOUNDS AND IMMUNE CHECKPOINT INHIBITORS | 2021-02-11 |
20210040135 | NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVES, AND USES THEREOF | 2021-02-11 |
20210040136 | SMALL MOLECULE DRUG CONJUGATES OF GEMCITABINE MONOPHOSPHATE | 2021-02-11 |
20210040137 | Oligonucleotide Conjugation Process | 2021-02-11 |
20210040138 | OXYSTEROLS AND METHODS OF USE THEREOF | 2021-02-11 |
20210040139 | COMPOSITION FOR CLEARING SPHEROIDS, METHOD FOR CLEARING SPHEROIDS USING SAME, AND KIT COMPRISING SAME | 2021-02-11 |
20210040140 | Steroid Derivative FXR Agonist | 2021-02-11 |
20210040141 | 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF | 2021-02-11 |
20210040142 | C17 POLAR-SUBSTITUTED HETEROAROMATIC SYNTHETIC TRITERPENOIDS AND METHODS OF USE THEREOF | 2021-02-11 |
20210040143 | SAPONIN-BASED VACCINE ADJUVANTS | 2021-02-11 |
20210040144 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | 2021-02-11 |
20210040145 | MEANS AND METHODS FOR SITE-SPECIFIC FUNCTIONALIZATION OF POLYPEPTIDES | 2021-02-11 |
20210040146 | PROTEIN PURIFICATION PROCESS | 2021-02-11 |
20210040147 | POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS | 2021-02-11 |
20210040148 | THERAPEUTICS FOR THE TREATMENT OF GLAUCOMA | 2021-02-11 |
20210040149 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | 2021-02-11 |
20210040151 | MICROMOLECULE POLYPEPTIDE AND USE THEREOF | 2021-02-11 |
20210040152 | PEPTIDES FOR TREATING TELOMERE DYSFUNCTION-ASSOCIATED DISEASES AND USES THEREOF | 2021-02-11 |
20210040153 | OLIGOPEPTIDE HAVING DENGUE VIRUS REPLICATION INHIBITION FUNCTION AND APPLICATION THEREOF | 2021-02-11 |
20210040154 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEX | 2021-02-11 |
20210040155 | PEPTIDE COMPOSITIONS | 2021-02-11 |
20210040156 | CAPSID-MODIFIED RAAV VECTORS AND METHODS OF USE | 2021-02-11 |
20210040157 | PARVOVIRUS STRUCTURAL PROTEIN FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2021-02-11 |
20210040158 | RECOMBINANT VIRAL VECTORS | 2021-02-11 |
20210040159 | CPG AMPHIPHILES AND USES THEREOF | 2021-02-11 |
20210040160 | HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS | 2021-02-11 |
20210040161 | MODULAR DIMERIZATION THERMOSWITCHES AND RELATED MONOMERS, DIMERS, CONSTRUCTS, DIMERIC COMPLEXES, VECTORS, CELLS, SURFACES, DEVICES COMPOSITIONS, METHODS AND SYSTEMS | 2021-02-11 |
20210040162 | IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM BOVIS SURFACE PROTEINS AND USES THEREOF | 2021-02-11 |
20210040163 | MSP NANOPORES AND USES THEREOF | 2021-02-11 |
20210040164 | PEPTIDE LIGASE-MEDIATED ENGINEERING OF RECOMBINANT NUCLEOSOMES | 2021-02-11 |
20210040165 | PD-1 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE | 2021-02-11 |
20210040166 | MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS | 2021-02-11 |
20210040167 | ENGINEERED VEGF VARIANTS FOR RETINAL NEUROPROTECTION, PROMOTION OF AXON GROWTH AND AXON REGENERATION | 2021-02-11 |
20210040168 | IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY | 2021-02-11 |
20210040169 | GENETICALLY REPROGRAMMED TREGS EXPRESSING MEMBRANE-BOUND IL-10 | 2021-02-11 |
20210040170 | GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE | 2021-02-11 |
20210040171 | PHARMACEUTICAL COMPOSITION COMPRISING ACYLATED DERIVATIVE OF HUMAN INSULIN ANALOG AND PREPARATION METHOD THEREOF | 2021-02-11 |
20210040172 | TARGETED DELIVERY OF GLYCINE RECEPTORS TO EXCITABLE CELLS | 2021-02-11 |
20210040173 | ANTIBODIES TO MICA AND MICB PROTEINS | 2021-02-11 |
20210040174 | Composition and Use of Humoral Immune Suppressor Antagonists for the Treatment of Humoral Immune Suppressed Diseases | 2021-02-11 |
20210040175 | Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation | 2021-02-11 |
20210040176 | HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE | 2021-02-11 |
20210040177 | Multi-Specific Molecules | 2021-02-11 |
20210040178 | Single-Chain Trail-Receptor Agonist Proteins | 2021-02-11 |
20210040179 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF WOUNDS | 2021-02-11 |
20210040180 | CD137 Binding Fibronectin Type III Domains | 2021-02-11 |
20210040181 | TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR | 2021-02-11 |
20210040182 | HUMANIZED ANTIBODIES | 2021-02-11 |
20210040183 | ANTIBODIES THAT POTENTLY NEUTRALIZE HEPATITIS B VIRUS AND USES THEREOF | 2021-02-11 |
20210040184 | ANTI-HIV ANTIBODIES | 2021-02-11 |
20210040185 | ANTI-HIV ANTIBODIES | 2021-02-11 |
20210040186 | MONOCLONAL ANTIBODIES DIRECTED AGAINST TRIMERIC FORMS OF THE HIV-1 ENVELOPE GLYCOPROTEIN WITH BROAD AND POTENT NEUTRALIZING ACTIVITY | 2021-02-11 |
20210040187 | NANOBODIES SUITABLE FOR NEURON REGENERATION THERAPY | 2021-02-11 |
20210040188 | Humanized Antibodies That Recognize Alpha-Synuclein | 2021-02-11 |
20210040189 | DKK1 ANTIBODIES AND METHODS OF USE | 2021-02-11 |
20210040190 | TREATING REFRACTORY MIGRAINE | 2021-02-11 |
20210040191 | TREATING REFRACTORY MIGRAINE | 2021-02-11 |
20210040192 | METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY | 2021-02-11 |
20210040193 | ANTI-PD-1/ANTI-VEGF NATURAL ANTIBODY STRUCTURE LIKE HETERODIMERIC FORM BISPECIFIC ANTIBODY AND PREPARATION THEREOF | 2021-02-11 |
20210040194 | ANTI-VEGF-A AND ANTI-ANG2 ANTIBODIES AND USES THEREOF | 2021-02-11 |
20210040195 | Treatment and Prevention of Cardiovascular Disease | 2021-02-11 |
20210040196 | METHOD OF TREATING EARLY STAGE DUPUYTREN'S DISEASE | 2021-02-11 |
20210040197 | NOVEL ANTIGEN BINDING MOLECULE FORMATS | 2021-02-11 |